Notably, recent research has notably highlighted the upregulation of the Y chromosome gene KDM5D in KRAS-mutated CRC, which influences tumor cell adhesion and immune responses through the KRAS-STAT4 signaling pathway [109]. The gene discussed is KRAS; the disease is neoplasm.